You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How often should i have my cholesterol checked while taking vascepa and statins?

See the DrugPatentWatch profile for vascepa

The frequency of cholesterol checks while taking Vascepa and statins may depend on various factors, including your cholesterol levels, medical history, and your doctor's recommendation.

Vascepa (icosapent ethyl) is a prescription medication used along with a low-fat and low-cholesterol diet to lower high levels of triglycerides, a type of fat in the blood [1]. Statins are a class of drugs often prescribed to help lower cholesterol levels [2].

The American College of Cardiology and the American Heart Association recommend that adults who have cardiovascular disease or who are at high risk for it have their cholesterol checked annually or more frequently as directed by their healthcare provider [3]. If you are taking Vascepa and statins, your healthcare provider may recommend more frequent cholesterol checks to monitor your response to treatment [4].

However, it is important to note that the optimal frequency of cholesterol checks while taking Vascepa and statins may vary for each individual. Therefore, it is best to follow your healthcare provider's recommendation.

In summary, the frequency of cholesterol checks while taking Vascepa and statins may depend on various factors, and it is best to follow your healthcare provider's recommendation.

Sources:
[1] "Vascepa." Drugs.com, www.drugs.com/vascepa.html.
[2] "Statins." Mayo Clinic, Mayo Foundation for Medical Education and Research, 15 Jan. 2022, www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statins/art-20045946.
[3] "Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines." Circulation, American Heart Association, 5 Nov. 2013, www.ahajournals.org/doi/10.1161/01.cir.0000437739.63853.7a.
[4] "Icosapent Ethyl (Vascepa): A Novel Therapeutic Option for High Triglycerides." DrugPatentWatch, 2021, www.drugpatentwatch.com/articles/icosapent-ethyl-vascepa-a-novel-therapeutic-option-for-high-triglycerides.


Other Questions About Vascepa :  Is cross reactivity between vascepa and shellfish a concern? Are there specific supplements that affect vascepa s efficacy? Are there allergic reaction risks with vascepa?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy